iron deficiency anaemia In patients undergoing cardiac surgery. Iron deficiency anaemia, unspecified
Conditions
Interventions
Intervention 1: Iron sucrose group:Patients in this group receive 1000 mg of an Iron sucrose drug by injection and within 3 weeks of surgery. Intervention 2: Ferric carboxymaltose group: Patients in t
Sponsors
Tabriz University of Medical Sciences
Blood Transfusion Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People over the age of 18 who are undergoing cardiac surgery for the first time. Men with Hb<13 and women with Hb<12 and (ferritin 100-299 ng / ml and transferransfine saturation < 20%) People who have discontinued the Warfarin at least 72 hours before surgery. People who have discontinued the anti-platelet at least drugs 3-5 days bofore sugery.
Exclusion criteria
Exclusion criteria: Elimination of patients with liver disorders Elimination of patients with inherited and well-known coagulation disorders Elimination Emergency sugeries Elimination pregnant women Redo surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Amount of ferritin changes in 2 groups studied. Timepoint: Before surgery and 3 days after surgery. Method of measurement: Ferritin Test.;2)Amount of Hb changes l in 2 groups studied. Timepoint: Before surgery and 3 days after surgery. Method of measurement: CBC Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) frequency of patients who transfused. Timepoint: 7 days after surgery. Method of measurement: Check patient records for the number of blood units consumed.;2) Average number of blood units consumed. Timepoint: 7 days after surgery. Method of measurement: Check patient records for the number of blood units consumed. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham KHalaf Adeli
Blood Transfusion Center
Outcome results
None listed